[1]
T. Žunić and M. Ponjavić, “The role of novel antihyperglycaemic agents in the treatment of Type 2 diabetes - from glycaemic control to cardiovascular protection”, arhfarm, vol. 70, no. Notebook 4, pp. 198–223, Aug. 2020, doi: 10.5937/arhfarm70-26987.